Skip to main content

Elevance Health Inc Value Stock - Dividend - Research Selection

Anthem

ISIN: US0367521038 , WKN: A12FMV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


How Investors May Respond To Elevance Health (ELV) Mixed Results, Softer 2026 Outlook And Higher Payouts

2026-02-08
Elevance Health has reported past fourth-quarter 2025 revenue of US$49,747 million and full-year revenue of US$199.13 billion, with full-year net income easing to US$5,662 million and diluted EPS from continuing operations at US$25.21. Alongside this mixed profit picture, the company signaled a low single digit decline in 2026 operating revenue, while still raising its quarterly dividend to US$1.72 per share and continuing share repurchases. Next, we’ll examine how softer 2026 earnings...

Will Declining Medical Membership Affect Humana's Q4 Earnings?

2026-02-06
HUM heads into Q4 with declining medical membership and rising costs, clouding earnings despite expectations for solid revenue growth.

Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength

2026-02-06
CNC incurs a Q4 adjusted loss per share as medical costs spike, but revenues jump nearly 22% on strong PDP and Marketplace premium growth.

Ensign Group Q4 Earnings Beat Estimates on Growing Occupancy

2026-02-06
ENSG tops Q4 EPS estimates as occupancy rose sharply, lifting earnings nearly 20% year over year despite higher costs and a slight revenue miss.

S&P 500 Health Insurer Dives As ACA Enrollment Implodes

2026-02-06
S&P 500 health insurer Molina Healthcare crashed to a nearly six-year low on Friday morning after posting an unexpected loss amid surging health benefit costs. Centene, another S&P 500 member, also reported a loss, though that was anticipated. Molina said that it expects insured Affordable Care Act Marketplace membership to sink from 713,000 at the end of Q3 to just 220,000 at the end of 2026.

Molina Healthcare Incurs a Loss in Q4 as Medical Costs Surge

2026-02-06
Molina Healthcare posts Q4 loss as medical costs surge, even as revenues rise 8% and full-year sales top expectations.

3Q Profit Margins for Aggregate Blues Plans Analyzed by Mark Farrah Associates

2026-02-05
PITTSBURGH, February 05, 2026--MFA assessed profit margin trends of Blue Cross Blue Shield (BCBS) plans, and compared year-over-year performance, as of September 2025.

Capital Allocation Trends At Elevance Health (NYSE:ELV) Aren't Ideal

2026-02-04
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Fire

2026-02-04
UnitedHealth Group Inc. (NYSE:UNH), CVS Health Corp. (NYSE:CVS), and Humana Inc. (NYSE:HUM) declined last week, but while investors focused on the Donald Trump administration’s proposed near-zero increase in Medicare Advantage, another major regulatory threat emerged late Thursday that could squeeze the industry’s profits from the other end. Shining A Light On ‘Ghost’ Billions The U.S. Department of Labor (DOL), on Jan. 29, issued a landmark proposed regulation demanding “radical transparency” f

5 Revealing Analyst Questions From Elevance Health’s Q4 Earnings Call

2026-02-04
Elevance Health’s fourth quarter was marked by ongoing pressures in its core Medicaid and Medicare businesses, but management credited disciplined portfolio adjustments and cost management for maintaining performance aligned with expectations. CEO Gail Boudreaux highlighted that the company’s actions to reposition its book of business—such as exiting lower-margin geographies and tightening pricing—were aimed at stabilizing margins and setting a foundation for future growth. The quarter also saw